These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

818 related items for PubMed ID: 17000005

  • 1. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.
    Owen CE.
    Pharmacol Ther; 2007 Jan; 113(1):121-33. PubMed ID: 17000005
    [Abstract] [Full Text] [Related]

  • 2. Anti-immunoglobulin E therapy for asthma.
    Owen CE.
    Pulm Pharmacol Ther; 2002 Jan; 15(5):417-24. PubMed ID: 12406663
    [Abstract] [Full Text] [Related]

  • 3. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.
    Holgate S, Casale T, Wenzel S, Bousquet J, Deniz Y, Reisner C.
    J Allergy Clin Immunol; 2005 Mar; 115(3):459-65. PubMed ID: 15753888
    [Abstract] [Full Text] [Related]

  • 4. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
    D'Amato G.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):302-7. PubMed ID: 16464445
    [Abstract] [Full Text] [Related]

  • 5. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases.
    Chang TW, Wu PC, Hsu CL, Hung AF.
    Adv Immunol; 2007 Mar 08; 93():63-119. PubMed ID: 17383539
    [Abstract] [Full Text] [Related]

  • 6. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.
    Nowak D.
    Respir Med; 2006 Nov 08; 100(11):1907-17. PubMed ID: 16949266
    [Abstract] [Full Text] [Related]

  • 7. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST, Djukanović R, Casale T, Bousquet J.
    Clin Exp Allergy; 2005 Apr 08; 35(4):408-16. PubMed ID: 15836747
    [Abstract] [Full Text] [Related]

  • 8. Anti-IgE therapy with omalizumab in asthma and allergic rhinitis.
    Dodig S, Richter D, Cepelak I, Benko B.
    Acta Pharm; 2005 Jun 08; 55(2):123-38. PubMed ID: 16179127
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma].
    Michils A, Sternon J.
    J Pharm Belg; 2006 Jun 08; 61(3):83-7. PubMed ID: 17058881
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Omalizumab: efficacy in allergic disease.
    Spector S.
    Panminerva Med; 2004 Jun 08; 46(2):141-8. PubMed ID: 15507883
    [Abstract] [Full Text] [Related]

  • 15. [Role of monoclonal anti-IgE antibodies (rhu-MAb) in the treatment of allergic bronchial asthma].
    Targowski T, From S.
    Pol Merkur Lekarski; 2003 Jan 08; 14(79):65-8. PubMed ID: 12712834
    [Abstract] [Full Text] [Related]

  • 16. Anti-IgE therapy of asthma.
    Chung KF.
    Curr Opin Investig Drugs; 2002 Aug 08; 3(8):1157-60. PubMed ID: 12211407
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.